At the MedCity CONVERGE conference, medical oncologist Dr. Joshua Brody, the director of the lymphomaimmunotherapy program at Mount Sinai Hospital, talked about some of the hype and hope of CAR-T and checkpoint blockade immunotherapy treatments.
More From BioPortfolio on "The Benihana of cancer vaccines: How are medical oncologists advancing immunotherapy?"